Literature DB >> 24130974

Antinuclear antibody test.

Michael O'Sullivan1, Andrew McLean-Tooke, Richard K S Loh.   

Abstract

The antinuclear antibody (ANA) test is widely used as a serological marker of autoimmune disease. Antinuclear antibodies are immunoglobulins or antibodies that bind to one or more antigens expressed within the nucleus of human cells. Used selectively, the ANA test can be a useful laboratory tool to help confirm or exclude the diagnosis of systemic rheumatic disease. However, the relatively high prevalence of ANAs in other inflammatory conditions, as well as healthy individuals, can make a positive result difficult to interpret.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24130974

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  8 in total

Review 1.  Auto immune hepatitis.

Authors:  Nicole Mf van Gerven; Ynto S de Boer; Chris Jj Mulder; Carin Mj van Nieuwkerk; Gerd Bouma
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

2.  The prevalence of antinuclear antibodies in patients with sarcoidosis.

Authors:  Senol Kobak; Hatice Yilmaz; Fidan Sever; Arzu Duran; Nazime Sen; Ahmet Karaarslan
Journal:  Autoimmune Dis       Date:  2014-12-17

3.  Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.

Authors:  Manas K Akmatov; Nadja Röber; Wolfgang Ahrens; Dieter Flesch-Janys; Julia Fricke; Halina Greiser; Kathrin Günther; Rudolf Kaaks; Yvonne Kemmling; Bastian Krone; Jakob Linseisen; Christa Meisinger; Susanne Moebus; Nadia Obi; Carlos A Guzman; Karsten Conrad; Frank Pessler
Journal:  Arthritis Res Ther       Date:  2017-06-06       Impact factor: 5.156

4.  Pediatric systemic lupus erythematosus. Retrospective analysis of clinico-laboratory parameters and their association with Systemic Lupus Erythematosus Disease Activity Index score.

Authors:  Siti Khadijah S M Nazri; Kah K Wong; Wan Zuraida W A Hamid
Journal:  Saudi Med J       Date:  2018-06       Impact factor: 1.484

Review 5.  Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications.

Authors:  Bogna Grygiel-Górniak; Natalia Rogacka; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2018-08-31

6.  Streamlining the Diagnosis of Atypical Facial Palsies: A 5-year Review of 805 Patients.

Authors:  Lok Ka Cheung; Ruben Y Kannan; Catriona Neville; Tamsin Gwynn; Karen Young; Rosanna C Ching; Charles Nduka
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-02-09

7.  Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study.

Authors:  Mara Oleszowsky; Matthias F Seidel
Journal:  Biomed Res Int       Date:  2018-02-01       Impact factor: 3.411

8.  Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening.

Authors:  Sumi Yoon; Hee-Won Moon; Hanah Kim; Mina Hur; Yeo-Min Yun
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.